Prime Insights

    Clinical programs

April 29, 2016 | Kevin Bowen

4.5-year study finds diabetes and related drug costs surging

By 2050, as many as 1 in 3 adults in the United States will have diabetes. Coupled with drug price inflation, rising diabetic drug use has led to mounting costs for plan sponsors. To help measure the impact of rising use and costs, our team dove deep into Prime’s data to study diabetes prevalence, incidence and drug therapy.

What we learned | Study poster


April 26, 2016 | Cathy Starner

Can alerts at the pharmacy counter help curb opioid use?

Opioid misuse has emerged as an epidemic. The Centers for Medicare and Medicaid Services has implemented an opioid overutilization monitoring system. But is it enough? My team and I recently explored whether additional opportunity to curb opioid use existed. 

What we learned | Study poster


April 22, 2016 | Cathy Starner

Taken together, triple threat drugs prove dangerous — and costly

As administrators of prescription drug programs, pharmacy benefit managers can play an important role in helping prevent opioid overdose deaths. Prime reviewed data from 15 million members to study the impact of “Triple Threat” drug use.

What we learned | Study poster


Nov. 25, 2015 | Prime Therapeutics

Pilot study proves value of high-risk medicine interventions for Medicare beneficiaries

Health care spend among U.S. seniors is wildly disproportionate. At 13 percent, those ages 65 and older make up a small segment of the population. Yet they account for more than one-third of all health care costs — spending at a rate three times that of the average working-age person.

Study analysis


Nov. 5, 2015 | Cathy Starner

Engaging Medicare members improves adherence, can lead to higher Star ratings

To learn how MTM programs impact adherence — and eventually Star ratings — our team of researchers analyzed pharmacy claims data for 1.2 million Medicare members. We compared adherence between qualified members who engaged in MTM* vs. those who did not within the three drug adherence Star ratings  categories: diabetes, statins and renin angiotensin system (RAS) antagonists.

Study analysis


April 7, 2014 | Patrick Gleason

Custom care can help specialty members stay the course

Members on specialty drugs often have complex and costly drug regimens. Prime Specialty Pharmacy offers a number of high-touch services designed to improve the quality of care for these individuals. This analysis suggests that providing members with services beyond what they receive at retail – such as benefits coordination, customized care, and payment assistance – is important to helping them stay on their medicines.

Study analysis